Insufficient scRNA-seq data for expression of HOGA1 at single-cell level.
Insufficient scRNA-seq data for expression of HOGA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3397.34 | 89 / 89 | 96% | 23.14 | 861 / 901 |
brain | 97% | 376.04 | 2568 / 2642 | 94% | 5.63 | 665 / 705 |
liver | 100% | 2814.40 | 226 / 226 | 91% | 10.54 | 369 / 406 |
adrenal gland | 100% | 844.28 | 258 / 258 | 90% | 4.96 | 207 / 230 |
pancreas | 100% | 651.42 | 328 / 328 | 57% | 2.20 | 102 / 178 |
skin | 78% | 137.37 | 1416 / 1809 | 63% | 2.31 | 295 / 472 |
lung | 79% | 157.06 | 457 / 578 | 24% | 0.57 | 281 / 1155 |
blood vessel | 96% | 492.37 | 1284 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 1024.34 | 810 / 861 | 0% | 0 | 0 / 0 |
thymus | 74% | 118.51 | 485 / 653 | 19% | 0.51 | 116 / 605 |
adipose | 93% | 287.96 | 1123 / 1204 | 0% | 0 | 0 / 0 |
breast | 72% | 189.53 | 332 / 459 | 16% | 0.32 | 177 / 1118 |
eye | 0% | 0 | 0 / 0 | 86% | 4.18 | 69 / 80 |
uterus | 55% | 87.71 | 93 / 170 | 19% | 0.54 | 89 / 459 |
prostate | 64% | 107.22 | 158 / 245 | 9% | 0.17 | 47 / 502 |
muscle | 69% | 200.16 | 554 / 803 | 0% | 0 | 0 / 0 |
esophagus | 41% | 52.99 | 590 / 1445 | 20% | 0.40 | 37 / 183 |
ovary | 9% | 11.62 | 16 / 180 | 43% | 0.99 | 184 / 430 |
bladder | 19% | 19.67 | 4 / 21 | 22% | 0.51 | 110 / 504 |
intestine | 6% | 6.94 | 57 / 966 | 15% | 0.30 | 79 / 527 |
stomach | 3% | 4.07 | 10 / 359 | 15% | 0.28 | 42 / 286 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.12 | 3 / 45 |
peripheral blood | 4% | 6.95 | 35 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 3.87 | 6 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033609 | Biological process | oxalate metabolic process |
GO_0019470 | Biological process | 4-hydroxyproline catabolic process |
GO_0042866 | Biological process | pyruvate biosynthetic process |
GO_0046487 | Biological process | glyoxylate metabolic process |
GO_0009436 | Biological process | glyoxylate catabolic process |
GO_0019262 | Biological process | N-acetylneuraminate catabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0008700 | Molecular function | 4-hydroxy-2-oxoglutarate aldolase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0106009 | Molecular function | (4S)-4-hydroxy-2-oxoglutarate aldolase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008747 | Molecular function | N-acetylneuraminate lyase activity |
Gene name | HOGA1 |
Protein name | 4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase) (Protein 569272) 4-hydroxy-2-oxoglutarate aldolase 1 |
Synonyms | C10orf65 DHDPSL |
Description | FUNCTION: Catalyzes the final step in the metabolic pathway of hydroxyproline. . |
Accessions | ENST00000370642.4 Q86XE5 ENST00000370646.9 [Q86XE5-1] H7BY76 ENST00000370647.8 [Q86XE5-3] |